Aegerion Pharmaceuticals (AEGR 12.1%) is flying this morning after Capstone initiates the shares...

|About: Aegerion Pharmaceuticals (AEGR)|By:, SA News Editor

Aegerion Pharmaceuticals (AEGR 12.1%) is flying this morning after Capstone initiates the shares with a Buy. The coverage comes on the back of last week's initiation at Overweight by JPMorgan, and just ahead of an FDA advisory meeting scheduled for October 17 - 18 to debate the risks and benefits of AEGR's experimental drug Lomitapide NDA, for the treatment of homozygous familial hypercholesterolemia. The advisory panel recommendations often heavily influence FDA approval decisions.